Inovio Pharmaceuticals appoints Jeffrey Libson to board
INO•Inovio Pharmaceuticals appointed Jeffrey Libson to its board and Finance Committee, effective November 13, 2026, expanding the board from eight directors to nine.
1. Board appointment
Libson’s appointment became effective November 13, 2026, and his board term runs through the 2027 annual stockholders meeting. He also joined the Finance Committee. Libson was a Cooley partner from December 2016 to January 2025, advising life sciences companies, boards, entrepreneurs and investors.




